# Comparison of Tandospirone, Amlodipine and Their Combination in Adults With Hypertension and Anxiety

Study · id `cardio:ct-nct03667677` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03667677](<https://clinicaltrials.gov/study/NCT03667677>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03667677

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 256 participants.

## Technical summary

Registry record NCT03667677. Randomized; quadruple masking; primary purpose treatment. Start 2019-02-01 (anticipated); primary completion 2020-02-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 256 participants (planned count; ClinicalTrials.gov record NCT03667677, source copy `cardio:ctgov-nct03667677-2018-12-04`, retrieved 2026-10-26)
- Planned start: 2019-02-01 (anticipated) (ClinicalTrials.gov record NCT03667677, source copy `cardio:ctgov-nct03667677-2018-12-04`, retrieved 2026-10-26)
- Primary completion: 2020-02-01 (anticipated) (ClinicalTrials.gov record NCT03667677, source copy `cardio:ctgov-nct03667677-2018-12-04`, retrieved 2026-10-26)
- Completion: 2020-07-01 (anticipated) (ClinicalTrials.gov record NCT03667677, source copy `cardio:ctgov-nct03667677-2018-12-04`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT03667677, source copy `cardio:ctgov-nct03667677-2018-12-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03667677-2018-12-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of Tandospirone, Amlodipine and Their Combination in Adults With Hypertension and Anxiety
- Condition: Hypertension
- Condition: Anxiety
- Intervention (Drug): Tandospirone + Amlodipine
- Intervention (Drug): Tandospirone placebo + Amlodipine
- Intervention (Drug): Tandospirone + Amlodipine placebo
- Intervention (Drug): Tandospirone placebo + Amlodipine placebo
- Lead sponsor: Chongqing Medical University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Chongqing Medical University (`cardio:org-chongqing-medical-university`)

## Provenance

Content hash: 36dfc72cf7f40b199aae09271b4f79f0a903dcddb8c43660847eba4d4a0e2d57
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
